Literature DB >> 12435704

Structural basis for imipenem inhibition of class C beta-lactamases.

Beth M Beadle1, Brian K Shoichet.   

Abstract

To determine how imipenem inhibits the class C beta-lactamase AmpC, the X-ray crystal structure of the acyl-enzyme complex was determined to a resolution of 1.80 A. In the complex, the lactam carbonyl oxygen of imipenem has flipped by approximately 180 degrees compared to its expected position; the electrophilic acyl center is thus displaced from the point of hydrolytic attack. This conformation resembles that of imipenem bound to the class A enzyme TEM-1 but is different from that of moxalactam bound to AmpC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12435704      PMCID: PMC132770          DOI: 10.1128/AAC.46.12.3978-3980.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Improved methods for building protein models in electron density maps and the location of errors in these models.

Authors:  T A Jones; J Y Zou; S W Cowan; M Kjeldgaard
Journal:  Acta Crystallogr A       Date:  1991-03-01       Impact factor: 2.290

2.  Refined crystal structure of beta-lactamase from Citrobacter freundii indicates a mechanism for beta-lactam hydrolysis.

Authors:  C Oefner; A D'Arcy; J J Daly; K Gubernator; R L Charnas; I Heinze; C Hubschwerlen; F K Winkler
Journal:  Nature       Date:  1990-01-18       Impact factor: 49.962

3.  Processing of X-ray diffraction data collected in oscillation mode.

Authors:  Z Otwinowski; W Minor
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

4.  Evidence for an oxyanion hole in serine beta-lactamases and DD-peptidases.

Authors:  B P Murphy; R F Pratt
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

5.  Crystal structures of the Bacillus licheniformis BS3 class A beta-lactamase and of the acyl-enzyme adduct formed with cefoxitin.

Authors:  Eveline Fonzé; Marc Vanhove; Georges Dive; Eric Sauvage; Jean-Marie Frère; Paulette Charlier
Journal:  Biochemistry       Date:  2002-02-12       Impact factor: 3.162

6.  Functional analyses of AmpC beta-lactamase through differential stability.

Authors:  B M Beadle; S L McGovern; A Patera; B K Shoichet
Journal:  Protein Sci       Date:  1999-09       Impact factor: 6.725

7.  Inhibition of class C beta-lactamases: structure of a reaction intermediate with a cephem sulfone.

Authors:  G V Crichlow; M Nukaga; V R Doppalapudi; J D Buynak; J R Knox
Journal:  Biochemistry       Date:  2001-05-29       Impact factor: 3.162

8.  Noncovalent interaction energies in covalent complexes: TEM-1 beta-lactamase and beta-lactams.

Authors:  Xiaojun Wang; George Minasov; Brian K Shoichet
Journal:  Proteins       Date:  2002-04-01

9.  Crystallographic structure of a phosphonate derivative of the Enterobacter cloacae P99 cephalosporinase: mechanistic interpretation of a beta-lactamase transition-state analog.

Authors:  E Lobkovsky; E M Billings; P C Moews; J Rahil; R F Pratt; J R Knox
Journal:  Biochemistry       Date:  1994-06-07       Impact factor: 3.162

10.  Structure-based approach for binding site identification on AmpC beta-lactamase.

Authors:  Rachel A Powers; Brian K Shoichet
Journal:  J Med Chem       Date:  2002-07-18       Impact factor: 7.446

View more
  33 in total

1.  Structures of the Michaelis complex (1.2 Å) and the covalent acyl intermediate (2.0 Å) of cefamandole bound in the active sites of the Mycobacterium tuberculosis β-lactamase K73A and E166A mutants.

Authors:  Lee W Tremblay; Hua Xu; John S Blanchard
Journal:  Biochemistry       Date:  2010-10-25       Impact factor: 3.162

2.  Crystal structures of covalent complexes of β-lactam antibiotics with Escherichia coli penicillin-binding protein 5: toward an understanding of antibiotic specificity.

Authors:  George Nicola; Joshua Tomberg; R F Pratt; Robert A Nicholas; Christopher Davies
Journal:  Biochemistry       Date:  2010-09-21       Impact factor: 3.162

Review 3.  Understanding the structural mechanisms of antibiotic resistance sets the platform for new discovery.

Authors:  Stephanie M Reeve; Michael N Lombardo; Amy C Anderson
Journal:  Future Microbiol       Date:  2015-10-30       Impact factor: 3.165

4.  Site-saturation mutagenesis of position V117 in OXA-1 β-lactamase: effect of side chain polarity on enzyme carboxylation and substrate turnover.

Authors:  Jennifer S Buchman; Kyle D Schneider; Aaron R Lloyd; Stephanie L Pavlish; David A Leonard
Journal:  Biochemistry       Date:  2012-03-28       Impact factor: 3.162

5.  Structural insight into potent broad-spectrum inhibition with reversible recyclization mechanism: avibactam in complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-lactamases.

Authors:  Sushmita D Lahiri; Stefano Mangani; Thomas Durand-Reville; Manuela Benvenuti; Filomena De Luca; Gautam Sanyal; Jean-Denis Docquier
Journal:  Antimicrob Agents Chemother       Date:  2013-02-25       Impact factor: 5.191

6.  Biochemical and structural characterization of Mycobacterium tuberculosis beta-lactamase with the carbapenems ertapenem and doripenem.

Authors:  Lee W Tremblay; Fan Fan; John S Blanchard
Journal:  Biochemistry       Date:  2010-05-04       Impact factor: 3.162

7.  Trapping and characterization of a reaction intermediate in carbapenem hydrolysis by B. cereus metallo-beta-lactamase.

Authors:  Mariana F Tioni; Leticia I Llarrull; Andrés A Poeylaut-Palena; Marcelo A Martí; Miguel Saggu; Gopal R Periyannan; Ernesto G Mata; Brian Bennett; Daniel H Murgida; Alejandro J Vila
Journal:  J Am Chem Soc       Date:  2008-11-26       Impact factor: 15.419

8.  Engineering the synthetic potential of β-lactam synthetase and the importance of catalytic loop dynamics.

Authors:  Jason W Labonte; Fumitaka Kudo; Michael F Freeman; Mary L Raber; Craig A Townsend
Journal:  Medchemcomm       Date:  2012-01-01       Impact factor: 3.597

9.  A kinetic analysis of the inhibition of FOX-4 β-lactamase, a plasmid-mediated AmpC cephalosporinase, by monocyclic β-lactams and carbapenems.

Authors:  Krisztina M Papp-Wallace; Susana Mallo; Christopher R Bethel; Magdalena A Taracila; Andrea M Hujer; Ana Fernández; Julian A Gatta; Kerri M Smith; Yan Xu; Malcolm G P Page; Eric Desarbre; Germán Bou; Robert A Bonomo
Journal:  J Antimicrob Chemother       Date:  2013-11-13       Impact factor: 5.790

10.  Inhibition of class A beta-lactamases by carbapenems: crystallographic observation of two conformations of meropenem in SHV-1.

Authors:  Michiyosi Nukaga; Christopher R Bethel; Jodi M Thomson; Andrea M Hujer; Anne Distler; Vernon E Anderson; James R Knox; Robert A Bonomo
Journal:  J Am Chem Soc       Date:  2008-08-30       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.